Effects of entinostat onresistance to cetuximab and EGFR TKIs in non-small cell lung cancer

被引：0
|
作者：
Witta, Samir E.
Chan, Dan
Girard, Luc
Zheng, Di
Franekova, Veronica
Peyton, Michael
Zhang, Zhi-Yong
Kline, Zoe
Minna, John D.
Bunn, Paul A.
Hirsch, Fred R.
机构：
[1] Mt Blue Canc Care Ctr, Golden, CO USA
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[4] Univ Colorado, Ctr Canc, Denver, CO 80262 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18077
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cetuximab activity in non-small cell lung cancer is enhanced in vivo by the HDAC inhibitor entinostat
    Witta, Samir E.
    Girard, Luc
    Zheng Di
    Zhang Zhiyong
    Minna, John
    Bunn, Jr Paul A.
    Chan, Daniel C.
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S597 - S598
  • [2] Cetuximab in non-small cell lung cancer
    Ademuyiwa, Foluso O.
    Hanna, Nasser
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (01) : 107 - 113
  • [3] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yinan Yu
    Jianguo Zhao
    Jiaona Xu
    Rui Bai
    Zewei Gu
    Xialin Chen
    Jianfang Wang
    Xueying Jin
    Gaoyang Gu
    Current Treatment Options in Oncology, 2023, 24 : 1935 - 1947
  • [4] Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
    Yu, Yinan
    Zhao, Jianguo
    Xu, Jiaona
    Bai, Rui
    Gu, Zewei
    Chen, Xialin
    Wang, Jianfang
    Jin, Xueying
    Gu, Gaoyang
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (12) : 1889 - 1916
  • [5] Safety of EGFR-TKIs for EGFR mutation-positive non-small cell lung cancer
    Zhou, Jia-Ying
    Liu, Si-Yang
    Wu, Yi-Long
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 589 - 599
  • [6] Clinical Efficacy and Safety of Apatinib Combined with EGFR - TKIs in Advanced Non-Small Cell Lung Cancer with EGFR - TKIs Resistance
    Song, X.
    Tian, R.
    Guo, Y.
    Zhang, X.
    Guo, W.
    Zhu, H.
    Shen, F.
    Xu, J.
    Zhang, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S590 - S590
  • [7] Novel TKIs in Non-Small Cell Lung Cancer
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1449 - S1449
  • [8] EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
    Reade, Chad A.
    Ganti, Apar Kishor
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 215 - 224
  • [9] Multibiomarker analysis homing in on EGFR-TKIs therapy in non-small cell lung cancer
    Bai, H.
    An, T.
    Zhuo, M.
    Zhao, J.
    Wu, M.
    Duan, J.
    Yang, L.
    Wang, Z.
    Wang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer
    Zhao, Dan
    Chen, Xuejing
    Qin, Na
    Su, Dan
    Zhou, Lijuan
    Zhang, Quan
    Li, Xi
    Zhang, Xinyong
    Jin, Mulan
    Wang, Jinghui
    SCIENTIFIC REPORTS, 2017, 7
12345